Stem
Cells:
Saving
Lives or Crossing Lines
Human Embryonic Stem Cell Policy
James A. Baker III Institute
for Public Policy
The University of Texas M.D. Anderson Cancer Center
The University of Texas Health
Science Center at Houston
and Baylor College of Medicine
November 20-21, 2004
Can and Should the U.S. Be a
Leader in Human
Embryonic Stem Cell Research?
The Science and Technology Forum
of the James A. Baker III Institute for Public Policy in conjunction
with The University of Texas M.D. Anderson Cancer Center, The University
of Texas Health Science Center at Houston, and Baylor College of
Medicine will bring together and present business and community
leaders, policymakers, ethicists, science journalists, and scientists
to find
new ways to engage the general public in a dialogue on these vital
issues: Should the United States be involved in this
type of research? What are the medical, political, and
economic consequences of letting other nations take over the
leadership role? How would the U.S. regulate the research if it
were allowed?
Agenda - Saturday, November 20, 2004
8:30
am
Introduction and Welcome Remarks |
|
|
Neal F. Lane, Ph.D., Edward A. and Hermena Hancock Kelly University Professor of Physics & Astronomy and
Senior Fellow, Science and Technology Policy, James A. Baker III Institute for Public Policy, Rice University
David W. Leebron, President, Rice University
The Honorable Edward P. Djerejian, Founding Director, James A. Baker III Institute for Public Policy
William R. Brinkley, Ph.D., Senior Vice President for Graduate Sciences and Dean of the Graduate School of Biomedical Sciences, Baylor College of Medicine
James T. Willerson, Ph.D., President and the Edward Randall III Chair in Internal Medicine, University of Texas Health Science Center at Houston, Chief of Cardiology, St. Luke's hospital and Medical Director and Chief of Cardiology, Texas Heart Institute
Richard E. Champlin, M.D., Chairman, Department of Blood and Marrow Transplantation, University of Texas MD Anderson Cancer Center
|
9:00 am
Opening Addresses: |
|
|
The Human Impact of Embryonic Stem Cell Research
Bernard Siegel, Executive Director, Genetics Policy Institute
|
|
What are Embryonic Stem Cells?
Lawrence S.B. Goldstein, Ph.D. , Professor of Cellular and Molecular Medicine, University of California, San Diego, School of Medicine
|
Moderator: |
Richard R. Behringer, Ph.D., Professor and Deputy Chair, Department of Molecular Genetics, The University of Texas MD Anderson Cancer Center |
Opening Keynote: |
"What Can Human Embryonic Stem Cells Do?" |
|
Jose B. Cibelli, D.V.M., Ph.D.,Professor of Animal Biotechnology, Michigan State University and Head of Cellular Reprogramming Laboratory, Department of Animal Science and Physiology |
Session 1: |
Human Embryonic Stem Cell Research |
|
Professor Dame Julia M. Polak, Professor of Endocrine Pathology, Imperial College, London
Steven A. Goldman, M.D., Ph.D., Professor and Chief, Division of Cell and Gene Therapy, Attending Neurologist and Dean-Zutes Chair in the Aging Brain, Department of Neurology, University of Rochester Medical Center
James T. Willerson, Ph.D., President and the Edward Randall III Chair in Internal Medicine, University of Texas Health Science Center at Houston, Chief of Cardiology, St. Luke's Hospital, and President-Elect and Medical Director,
Texas Heart Institute
Stephen Minger, Ph.D., Lecturer and Director of the Stem Cell Laboratory, King's College, London |
Discussion with Question and Answer Session |
|
Moderator:
|
Vivian Ho, Ph.D.
, James A. Baker III Institute Chair in Health Economics, Associate Professor, Department of Economics, Rice University
and Associate Professor, Department of Medicince, Baylor College of Medicine |
1:15 pm Session 2:
|
Current U.S. and U.K. Policy Perspectives on Human Embryonic Stem Cell Research |
|
Suzi Leather, Chair, Human Fertilisation and Embryology Authority (HFEA), UK
Lord Naren Patel, Chair of the UK Stem Cell Bank and Chairman, UK
Neal F. Lane, Ph.D., Edward A. and Hermena Hancock Kelly University Professor of Physics & Astronomy and
Senior Fellow, Science and Technology Policy, James A. Baker III Institute for Public Policy, Rice University
James F. Battey, M.D., Ph.D., Director, National Institute on Deafness and Other Communication Disorders
Gregory Glover, M.D., Partner, Ropes and Gray LLC.
|
Discussion with Question and Answer Session |
|
Session
3:
|
Saving Lives or Crossing Lines: The Controversy of Human Embryonic Stem Cell Research |
|
John A. Robertson, Vinson and Elkins Chair, University of Texas School of Law at Austin
Eric Cohen, Director of the Biotechnology & American Democracy Program, Ethics and Public Policy Center
Rebecca Dresser, Daniel Noyes Kirby Professor of Law and Professor of Ethics in Medicine, Washington University |
Discussion with Question and Answer Session |
|
5:30 pm - 6:30 pm - Reception
|
|
|
|